New impact metric

In an attempt to provide alternative metrics to the traditional journal impact factor, the open-access journal __Public Library of Science ONE__ announced that it will release a slew of alternative impact data about individual articles in the coming months. The new "articles-level metrics project" -- which will post usage data, page views, citations from linkurl:Scopus;http://info.scopus.com/ and linkurl:CrossRef,;http://www.crossref.org/ social networlking links, press coverage, comments, and

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
In an attempt to provide alternative metrics to the traditional journal impact factor, the open-access journal __Public Library of Science ONE__ announced that it will release a slew of alternative impact data about individual articles in the coming months. The new "articles-level metrics project" -- which will post usage data, page views, citations from linkurl:Scopus;http://info.scopus.com/ and linkurl:CrossRef,;http://www.crossref.org/ social networlking links, press coverage, comments, and user ratings for each of __PLoS ONE__'s thousands of articles -- was announced yesterday (Jan. 18) by linkurl:Peter Binfield,;=http://www.plos.org/about/people/one.html the journal's managing editor, at the linkurl:ScienceOnline'09;http://www.scienceonline09.com/ conference in Research Triangle Park, North Carolina.
"No one has any data other than [ISI] impact factors," Binfield told __The Scientist__. "Our idea is to throw up a bunch of metrics and see what people use." From its inception at the end of 2006, __PLoS ONE__ has eschewed the notion of impact factors. (It is not currently listed by the ISI Web of Science's rankings.) Binfield argued that the traditional impact factor judges a journal's overall performance, rather than assessing impact at the article-level. The new scheme, however, is aimed at evaluating each article on its own merits, regardless of the other papers in the same journal, he said. __PLoS ONE__ doesn't plan to crunch the data itself, though. "We're not being arrogant enough to make our own metric," said Binfield. Rather, he hopes that the journal's readers will use the information to come to their conclusions. "We're putting the data out there and letting the world figure it out." Eventually, Binfield hopes that readers will be able to personalize how they view the data, and sort articles according to the metric of their choice. "The more metrics we have, the more it'll lead to a dilution of any one [metric]," said linkurl:Bjoern Brembs,;http://bjoern.brembs.net/ a neuroscientist at the Free University of Berlin in Germany and member of __PLoS ONE__'s editorial board.
**__Related stories:__***linkurl:Impact factors and publishing research;http://www.the-scientist.com/article/display/13247/
[16th September 2002]*linkurl:PLoS plans to publish its own journals;http://www.the-scientist.com/article/display/19886/
[7th September 2001]*linkurl:Long-term vs. short-term journal impact: Does it matter?;http://www.the-scientist.com/article/display/17900/
[2nd February 1998] *linkurl:Dispelling a few common myths about journal citation impacts;http://www.the-scientist.com/article/display/17383/
[3rd February 1997]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies